Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer

This study aimed to retrospectively evaluate the circulating free DNA (cfDNA) level in patients with locally advanced breast cancer (LABC) having different neoadjuvant chemotherapy (NCT) responses and to investigate whether dynamic changes in cfDNA level could predict the effectiveness of NCT in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ge, Wang, Jingyi, Huang, Huaxing, Han, Xu, Xu, Jin, Veeramootoo, Jordee Selvamanee, Xia, Tiansong, Wang, Shui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131846/
https://www.ncbi.nlm.nih.gov/pubmed/32017472
http://dx.doi.org/10.1002/cam4.2906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131846/
https://www.ncbi.nlm.nih.gov/pubmed/32017472
http://dx.doi.org/10.1002/cam4.2906

Ejemplares similares